Page last updated: 2024-10-24

chlorambucil and Bone Marrow Neoplasms

chlorambucil has been researched along with Bone Marrow Neoplasms in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Bone Marrow Neoplasms: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhagat, P1
Sachdeva, MU1
Sharma, P1
Naseem, S1
Ahluwalia, J1
Das, R1
Varma, N1
Law, A1
Malhotra, P1

Reviews

1 review available for chlorambucil and Bone Marrow Neoplasms

ArticleYear
Primary bone marrow lymphoma is a rare neoplasm with poor outcome: case series from single tertiary care centre and review of literature.
    Hematological oncology, 2016, Volume: 34, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Bone Marrow; Bone Marrow Exam

2016